Abstract

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes

Author(s): Allen Loyd V Jr

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 214-217

Download in electronic PDF format for $75

Abstract

Enteral feeding has increased in recent years along with the various methods and equipment utilized. Oftentimes, it is necessary to administer medications via enteral tubes, and care must be observed to maintain the proper flow through the tubes. This is done by proper maintenance to prevent clogging and even removing clogs if they occur. Proper choice of a vehicle to administer a drug is critical for the patient to receive the benefit of drug therapy and to properly maintain the usefulness of the enteral feeding.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 250-256	Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Author(s): de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
Jul/Aug 2010 Pg. 276-282	Recommendations for Compounding Medications for Feeding Tube Administration Author(s): Klang Mark
May/Jun 2003 Pg. 206-207	Technology Spotlight: Tube Sealers Author(s): Jones Michael, Adams Susan
Jul/Aug 2000 Pg. 304	Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 383	Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 13	Omeprazole (Prilosec) in the Atypical Patient, Administration of Author(s): Kane Dana Lynn
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr